Poster # 95: Development of HSD17B13 Targeting siRNA-GalNAc as a Potential Therapy for Fibrosis in NASHSeptember 10, 2020September 10, 2020 Leave your questions or comments for the authors in the comment section, below. Click on the image to view the PDF. previousPoster # 94: Bacteriopheophorbide nanoemulsions as photodynamic therapy agentsnextPoster # 96: Comparison of the Antibacterial Effect of Tio2 and Ag Nanoparticles Prepared by Laser Ablation and Sol-Gel on Burn Related Bacteria